DLA Piper has advised Kartos Therapeutics. Kartos Therapeutics, a US-based clinical stage biotechnology company, has entered into an agreement to be acquired by the French biopharmaceutical…
Ipsen Acquires Kartos Therapeutics in US$1.75 Billion Deal
DLA Piper has advised Kartos Therapeutics. Kartos Therapeutics, a US-based clinical stage biotechnology company, has entered into an agreement to be acquired by the French biopharmaceutical…